Search for a security
Results
Equities (47)
- Equities (47)
- ETFs (1)
| Company | Symbol | Exchange | Country |
|---|---|---|---|
| Faron Pharmaceuticals Oy | FARN:LSE | London Stock ExchangePrimary | United Kingdom |
| Poolbeg Pharma PLC | POLB:LSE | London Stock ExchangePrimary | United Kingdom |
| Hemogenyx Pharmaceuticals PLC | HEMO:LSE | London Stock ExchangePrimary | United Kingdom |
| N4 Pharma PLC | N4P:LSE | London Stock ExchangePrimary | United Kingdom |
| Hikma Pharmaceuticals PLC | HIK:LSE | London Stock ExchangePrimary | United Kingdom |
| BridgeBio Pharma Inc | BBIO:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Milestone Pharmaceuticals Inc | MIST:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Phathom Pharmaceuticals Inc | PHAT:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Royalty Pharma PLC | RPRX:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Oric Pharmaceuticals Inc | ORIC:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Syndax Pharmaceuticals Inc | SNDX:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Collegium Pharmaceutical Inc | COLL:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Apellis Pharmaceuticals Inc | APLS:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Crinetics Pharmaceuticals Inc | CRNX:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Kiniksa Pharmaceuticals International PLC | KNSA:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| PMV Pharmaceuticals Inc | PMVP:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Amylyx Pharmaceuticals Inc | AMLX:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Acumen Pharmaceuticals Inc | ABOS:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| SpyGlass Pharma Inc | SGP:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Grand Pharmaceutical Group Ltd | 512:HKG | Hong Kong Stock ExchangePrimary | Hong Kong |
| Tianda Pharmaceuticals Ltd | 455:HKG | Hong Kong Stock ExchangePrimary | Hong Kong |
| Atea Pharmaceuticals Inc | AVIR:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Tarsus Pharmaceuticals Inc | TARS:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Olema Pharmaceuticals Inc | OLMA:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Recursion Pharmaceuticals Inc | RXRX:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Terns Pharmaceuticals Inc | TERN:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Ionis Pharmaceuticals Inc | IONS:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| BioMarin Pharmaceutical Inc | BMRN:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Regeneron Pharmaceuticals Inc | REGN:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Vertex Pharmaceuticals Inc | VRTX:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Rigel Pharmaceuticals Inc | RIGL:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| ACADIA Pharmaceuticals Inc | ACAD:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| West Pharmaceutical Services Inc | WST:NYQ | New York ConsolidatedPrimary | United States |
| Alnylam Pharmaceuticals Inc | ALNY:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| BioCryst Pharmaceuticals Inc | BCRX:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Arrowhead Pharmaceuticals Inc | ARWR:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Madrigal Pharmaceuticals Inc | MDGL:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Agios Pharmaceuticals Inc | AGIO:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Enanta Pharmaceuticals Inc | ENTA:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Ultragenyx Pharmaceutical Inc | RARE:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Indivior Pharmaceuticals, Inc | INDV:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Amphastar Pharmaceuticals Inc | AMPH:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Tonix Pharmaceuticals Holding Corp | TNXP:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Amneal Pharmaceuticals Inc | AMRX:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Cumberland Pharmaceuticals Inc | CPIX:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Ironwood Pharmaceuticals Inc | IRWD:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
| Jazz Pharmaceuticals PLC | JAZZ:NSQ | Consolidated Issue Listed on NASDAQ Global Select Primary | United States |
